RecruitingPhase 3NCT07743450
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Sponsor: Ascletis Pharma (China) Co., Limited
Banning, CA · Chula Vista, CA · Covina, CA · +81 more sites